Written by The Apheresis Market is expanding as healthcare systems increasingly adopt blood component separation technologies for therapeutic and donor applications. According to Market Research Future, the market was valued at approximately USD 1.2 billion in 2024 and is projected to reach about USD 3.1 billion by 2035, registering a CAGR of 9.0% from 2025 to 2035.
Technological advancements in apheresis equipment are supporting market development by improving efficiency, consistency, and patient-care capabilities. Automated systems are gaining importance as healthcare providers seek more efficient approaches for collecting plasma, platelets, and other blood components.
Therapeutic apheresis has applications across several medical areas, including cancer treatment, autoimmune disorders, neurological disorders, and renal disorders. The increasing prevalence of chronic diseases and demand for specialized blood component therapies are contributing to the adoption of apheresis procedures.
The market is segmented by product type, application, end user, and procedure type. Hospitals represent an important end-user segment, while blood donation centers are also increasing their use of apheresis technologies. North America currently represents the largest regional market, while Asia-Pacific is identified as a rapidly growing region.
Gain valuable insights through comprehensive industry analysis:
Urinary Incontinence Market Volume
Tattoo Removal Market Forecast